. Author manuscript; available in PMC: 2012 Aug 1.

Published in final edited form as: J Mol Med (Berl). 2011 May 10;89(8):753–769. doi: 10.1007/s00109-011-0764-0

Table 2.

Tumor cell lines predisposed to LNM

Cancer	Cell line	Parent cell line	Origin	Histology	Yield^a
Melanoma	B16-BL6 [113]	B16	C57BL/6J	Cutaneous	42–72% mice
Melanoma	B16-F10 [113]	B16	C57BL/6J	Cutaneous	18–82% mice
Breast	MDA-MB-231(LM1) [114]	MDA-MB-231	Human	Adenocarcinoma	92% LN
Breast	MDA-MB-435(LN435) [26]	MDA-MB-435	Human	Adenocarcinoma	NR
Head and neck	GDC185 [115]	–	Human	Squamous carcinoma	56–81% LN
	HSC-3-M3 [116]	HSC-3	Human	Squamous carcinoma	90% mice
	OSC-19 [117]	–	Human	Squamous carcinoma	81% mice
	MG14 [118]	SCC7	C3H/HeJ	Squamous carcinoma	NR
Lung	H460SM [119]	H460	Human	Adenocarcinoma	100% rats
	LLC [120]	–	C57BL/6	Adenocarcinoma	93% mice
	Ma44-3 [32]	Ma44	Human	Squamous carcinoma	83% mice
Gastrointestinal	MIA-PaCa2 [121]	–	Human	Ductal adenocarcinoma	NR
Gastrointestinal	OCUM-2M-LN [122]	OCUM	Human	Scirrhous carcinoma	100% mice
Prostate	PC3-LN4 [38]	PC-3	Human	Adenocarcinoma	100% mice

LN lymph node, NR not recorded

Pathologically confirmed metastases